News - United Therapeutics

Filter

Current filters:

United Therapeutics

Popular Filters

United Therapeutics subpoenaed over drug marketing practices

09-12-2013

US drugmaker United Therapeutics says it has received a subpoena from the Office of the Inspector General…

AdcircaLegalMarkets & MarketingNorth AmericaPharmaceuticalRemodulinTyvasoUnited Therapeutics

United Therapeutics sues Sandoz over Remodulin patent infringement

16-03-2012

United Therapeutics (Nasdaq: UTHR) says that it has filed a law suit in the US District Court for the…

Cardio-vascularGenericsLegalNorth AmericaNovartisPatentsPharmaceuticalRemodulinSandozUnited Therapeutics

Sandoz challenges United Thera’s Remodulin patents

06-02-2012

US drugmaker United Therapeutics (Nasdaq: UTHR) says that it has received a Paragraph IV Certification…

GenericsNorth AmericaNovartisPatentsPharmaceuticalRegulationRemodulinRespiratory and PulmonarySandozUnited Therapeutics

United Thera’s oral PAH drug treprostinil fails in Ph III study

26-08-2011

US biotech firm United Therapeutics (Nasdaq: UTHR) says that preliminary results from its FREEDOM-C(2)…

BiotechnologyRegulationResearchRespiratory and PulmonaryTreprostinilUnited Therapeutics

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top